From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat. [PDF]
Alsbrook S, Pro G, Koturbash I.
europepmc +1 more source
Association of behavioral economic demand for kratom with DSM-5 use disorder: quantity and likelihood-based demand approaches. [PDF]
Pierce-Messick Z +5 more
europepmc +1 more source
Cosmeceutical Potential of <i>Mitragyna speciosa</i> (Kratom): Anti-Adipogenic and Antioxidant Properties of Extracts and Mitragynine. [PDF]
Kaewchompoo S +5 more
europepmc +1 more source
Alkaloid biosynthesis in medicinal crop kratom (<i>Mitragyna speciosa</i>) varies with postharvest, genetic, and seasonal factors. [PDF]
Zhang M +6 more
europepmc +1 more source
7-Hydroxymitragynine and Nicotine Pouch Withdrawal Syndrome: A Case Report. [PDF]
Sharma A, Nair BS, Pemminati S.
europepmc +1 more source
Prevalence of antibiotic-resistant <i>Salmonella</i> in kratom: Three-year monitoring study. [PDF]
Peroutka V +3 more
europepmc +1 more source
Chronic photodistributed hyperpigmented patches in a middle-aged man. [PDF]
Cortes J, Haft M, Seidman J, Paravar T.
europepmc +1 more source
The acute adverse health effects of kratom: an evaluation of case reports. [PDF]
Smallets S +4 more
europepmc +1 more source
Is bedtime use of kratom (Mitragyna speciosa) a sleep aid or disruptor? Examining its daily effects and individual differences. [PDF]
Mun CJ +7 more
europepmc +1 more source
Hinchey Stage IV Diverticulitis in a Kratom User. [PDF]
Stout M, Gioe E, Smith MH.
europepmc +1 more source

